TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Telix Pharmaceuticals Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 20, 2026
$10.74+0.05 (+0.47%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Telix Pharmaceuticals has not reported a dividend
No dividend per share appears in Telix Pharmaceuticals's annual filings since fiscal 2022.